Staphylococcal Vaccines and Immunotherapies
- 1 March 2009
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 23 (1) , 153-171
- https://doi.org/10.1016/j.idc.2008.10.005
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Vaccine protection againstStaphylococcus aureuspneumoniaThe Journal of Experimental Medicine, 2008
- Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in MichiganAntimicrobial Agents and Chemotherapy, 2008
- Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti- Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2007
- Infection Control by Antibody Disruption of Bacterial Quorum Sensing SignalingChemistry & Biology, 2007
- Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive powerCurrent Opinion in Microbiology, 2007
- Vaccine assembly from surface proteins ofStaphylococcus aureusProceedings of the National Academy of Sciences, 2006
- Phase I Dose Escalation Study To Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring HemodialysisAntimicrobial Agents and Chemotherapy, 2006
- Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2006
- Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureusProceedings of the National Academy of Sciences, 2002